Drug Targeting Organ-Specific Strategies

References 253
[53] Nehls V, Drenckhahn D, Microvasc. Res. 1995, 50, 311–322.
[54] Nicosia RF, Bonanno E, Smith M, J. Cell Physiol. 1993, 154, 654–661.
[55] Brown KJ, Maynes SF, Bezos A, Maguire DJ, Ford MD, Parish CR, Lab. Invest. 1996, 75,
539–555.
[56] Wartenberg M, Gunther J, Hescheler J, Sauer H, Lab. Invest. 1998, 78, 1301–1314.
[57] Evans MJ, Kaufman MH, Nature 1981, 292, 154–156.
[58] Risau W, Sariola H, Zerwes HG, Sasse J, Ekblom P, Kemler R, Doetschman T, Development
1988, 102, 471–478.
[59] Vittet D, Prandini MH, Berthier R, Schweitzer A, Martin-Sisteron H, Uzan G, Dejana E, Blood
1996, 88, 3424–3431.
[60] Nguyen M, Shing Y, Folkman J, Microvasc. Res. 1994, 47, 31–40.
[61] Conrad TJ, Chandler DB, Corless JM, Klintworth GK, Lab. Invest. 1994, 70, 426–434.
[62] Algire GH, J. Natl Cancer Inst. 1943, 4, 1–11.
[63] Lichtenbeld HC, Barendsz-Janson AF, van Essen H, Struijker Boudier H, Griffioen AW, Hillen
HFP, Int. J. Cancer 1998, 77, 455–459.
[64] Shubik P, Feldman R, Garcia H, Warren BA, J. Natl Cancer Inst. 1976, 57, 769–774.
[65] Mahadevan V, Hart IR, Lewis GP, Cancer Res. 1989, 49, 415–419.
[66] Plunkett ML, Hailey JA, Lab. Invest. 1990, 62, 510–517.
[67] Jain RK, Schlenger K, Hockel M, Yuan F, Nature Med. 1997, 3, 1203–1208.
[68] Girard JP, Baekkevold ES, Yamanaka T, Haraldsen G, Brandtzaeg P, Amalric F, Am. J. Pathol.
1999, 155, 2043–2055.
[69] Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O’Reilly R, Bader BL, Hynes RO, Zhuang Y,
Manova K, Benezra R, Nature 1999, 401, 670–677.
[70] Wang HV, Chen ZF, Anderson DJ, Cell 1998, 93, 741–753.
[71] Pasqualini R, Ruoslahti E, Mol. Psychiatry 1996, 1, 423–423.
[72] Jacobson BS, Stolz DB, Schnitzer JE, Nature Med. 1996, 4, 408–414.
[73] Griffioen AW, Molema G, Pharmacol. Rev. 2000, 52, 237–268.
[74] Folkman J, Eur. J. Cancer 1996, 32A, 2534–2539.
[75] Plate KH, Breier G, Millauer B, Ullrich A, Risau W, Cancer Res. 1993, 53, 5822–5827.
[76] Ramakrishnan S, Olson TA, Bautch VL, Mohanraj D, Cancer Res. 1996, 56, 1324–1330.
[77] Olson TA, Mohanraj D, Roy S, Ramakrishnan S, Int. J. Cancer 1997, 73, 865–870.
[78] Arora N, Masood R, Zheng T, Cai J, Smith DL, Gill PS, Cancer Res. 1999, 59, 183–188.
[79] Davol P, Beitz JG, Mohler M, Ying W, Cook J, Lappi DA, Frackelton Jr AR, Cancer 1995, 76,
79–85.
[80] Chiaramonte R, Polizzi D, Bartolini E, Petroni D, Comi P, Anticancer Drug Des. 1997, 12,
649–657.
[81] Fulcher S, Lui GM, Houston LL, Ramakrishnan S, Burris T, Polansky J, Alvarado J, Invest. Ophthalmol.
Vis. Sci. 1988, 29, 755–759.
[82] Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Tornsey E, Charlton R, Parums DV, Jowett
T, Marchuk DA, Burn J, Diamond AG, Dev. Biol. 2000, 217, 42-53.
[83] Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP, Science
1999, 284, 1534–1537.
[84] Oshima M, Oshima H, Taketo MM, Dev. Biol. 1996, 179, 297–302.
[85] Miller DW, Grulich W, Karges B, Stahl S, Ernst M, Ramaswamy A, Sedlacek HH, Muller R,
Adamkiewicz J, Int. J. Cancer 1999, 81, 568–572.
[86] Seon BK, Matsuno F, Haruta Y, Kondo M, Barcos M, Clin. Cancer Res. 1997, 3, 1031–1044.
[87] Matsuno F, Haruta Y, Kondo M, Tsai H, Barcos M, Seon BK, Clin. Cancer Res. 1999, 5, 371–382.
[88] Tabata M, Konda M, Haruta Y, Seon BK, Int. J. Cancer. 1999, 82, 737–742.
[89] Eliceiri BP, Cheresh DA, J. Clin. Invest. 1999, 103, 1227–1230.
[90] Arap W, Pasqualini R, Ruoslahti E, Science 1998, 279, 377–380.
[91] Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D, Simmons
DL, Akbar AN, Lord JM, Salmon M, Nature 1999, 397, 534–539.
[92] Baluna R, Rizo J, Gordon BE, Ghetie V, Vitetta ES, Proc. Natl Acad. Sci. USA 1999, 96,
3957–3962.
[93] Burrows FJ, Thorpe PE, Proc. Natl Acad. Sci. USA 1993, 90, 8996–9000.
[94] Huang X, Molema G, King S, Watkins L, Edgington TS, Thorpe PE, Science 1997, 275, 547–550.
[95] Ran S, Gao B, Duffy S, Watkins L, Rote N, Thorpe PE, Cancer Res. 1998, 58, 4646–4653.
[96] Rettig WJ, Garin-Chesa P, Healy JH, Su SL, Jaffe EA, Old LJ, Proc. Natl Acad. Sci. USA 1992,
89, 10832–10836.